CD274 and neoplasm: For instance, PD-L1 proteins expressed on tumor-derived EVs have been proposed as biomarkers for predicting immunotherapy responses [6,7], while the ability of EVs to cross the blood–brain barrier has attracted interest for early diagnosis and targeted drug delivery in neurological diseases [2,8].